Study tracks early adoption of liver histotripsy treatment
It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology's adoption and use have progressed, a research team at the University of Virginia, led by Al…
Gaby Clark Scientific Editor Robert Egan Senior Editor This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: fact-checked pe... [4832 chars]